TipRanks
Advertisement
Advertisement

CYYNF Stock Latest News

Cynata defines target market for new options in capital raising
Company AnnouncementsCynata defines target market for new options in capital raising
3d ago
Cynata Therapeutics Launches Renounceable Entitlement Offer to Raise Capital
PremiumCompany Announcements
Cynata Therapeutics Launches Renounceable Entitlement Offer to Raise Capital
3d ago
Cynata Plans Issue of 18 Million Options to Support Capital Needs
PremiumCompany Announcements
Cynata Plans Issue of 18 Million Options to Support Capital Needs
3d ago
Cynata Therapeutics Launches Major Renounceable Pro Rata Offer
PremiumCompany Announcements
Cynata Therapeutics Launches Major Renounceable Pro Rata Offer
3d ago
Cynata launches discounted entitlement offer to fund strategic review
PremiumCompany Announcements
Cynata launches discounted entitlement offer to fund strategic review
3d ago
Cynata Ends Equity Facility With Acuity, Plans Buyback of Security Shares
PremiumCompany AnnouncementsCynata Ends Equity Facility With Acuity, Plans Buyback of Security Shares
3d ago
Cynata Uses $1.7m R&D Refund to Clear Loan and Bolster Cymerus Strategy
Premium
Company Announcements
Cynata Uses $1.7m R&D Refund to Clear Loan and Bolster Cymerus Strategy
4d ago
Cynata Extends R&D Tax Incentive Loan Ahead of $1.7m Rebate
Premium
Company Announcements
Cynata Extends R&D Tax Incentive Loan Ahead of $1.7m Rebate
11d ago
Cynata Updates Corporate Governance Framework to Strengthen Board Oversight
PremiumCompany Announcements
Cynata Updates Corporate Governance Framework to Strengthen Board Oversight
13d ago
Cynata Releases 2025/2026 Annual Report and Confirms Corporate Structure
PremiumCompany Announcements
Cynata Releases 2025/2026 Annual Report and Confirms Corporate Structure
13d ago
Cynata Adjusts 2026 Results After GvHD Trial Close-Out Accrual
PremiumCompany Announcements
Cynata Adjusts 2026 Results After GvHD Trial Close-Out Accrual
17d ago
Cynata Options Lapse, Streamlining ASX-Listed Capital Structure
PremiumCompany Announcements
Cynata Options Lapse, Streamlining ASX-Listed Capital Structure
1M ago
Cynata narrows loss but trial setbacks and cash squeeze deepen going-concern risk
PremiumCompany AnnouncementsCynata narrows loss but trial setbacks and cash squeeze deepen going-concern risk
1M ago
Cynata Plans ASX-Quoted Share Placement to Raise Capital
Premium
Company Announcements
Cynata Plans ASX-Quoted Share Placement to Raise Capital
2M ago
Cynata Slashes Costs After Key Cell Therapy Trials Miss Efficacy Targets
Premium
Company Announcements
Cynata Slashes Costs After Key Cell Therapy Trials Miss Efficacy Targets
2M ago
Cynata Options Lapse Clarifies Future Equity Structure
PremiumCompany Announcements
Cynata Options Lapse Clarifies Future Equity Structure
3M ago
Cynata Discloses Final Director Interest as Dr Darryl Maher Departs Board
PremiumCompany Announcements
Cynata Discloses Final Director Interest as Dr Darryl Maher Departs Board
3M ago
Cynata Slashes Costs, Axes Staff and Taps R&D Loan to Extend Cash Runway
PremiumCompany Announcements
Cynata Slashes Costs, Axes Staff and Taps R&D Loan to Extend Cash Runway
3M ago
Major Shareholder FIL Limited Exits Position in Cynata Therapeutics
PremiumCompany Announcements
Major Shareholder FIL Limited Exits Position in Cynata Therapeutics
3M ago
Bioscience Fund Exits Substantial Holding in Cynata Therapeutics
PremiumCompany AnnouncementsBioscience Fund Exits Substantial Holding in Cynata Therapeutics
4M ago
Cynata to Host Investor Webinar on Results Update
Premium
Company Announcements
Cynata to Host Investor Webinar on Results Update
4M ago
Cynata’s CYP-004 Fails to Outperform Placebo in Phase 3 Knee Osteoarthritis Trial
Premium
Company Announcements
Cynata’s CYP-004 Fails to Outperform Placebo in Phase 3 Knee Osteoarthritis Trial
4M ago

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >